American Society of Clinical Oncology

SHERPA: White

People

  1. Ilson
    Ilson
  2. Bains
    Bains
  3. Rusch
    Rusch
  4. Kelsen
    Kelsen
  5. Janjigian
    Janjigian
  6. Wu
    Wu
  7. Capanu
    Capanu
  8. Park
    Park
  9. Kriplani
    Kriplani
  10. Ku
    Ku

Groups

  1. Department of Medicine (10)
  2. Gastrointestinal Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
  4. Surgery (8)
  5. Center for Pancreatic Cancer Research (7)
  6. Survivorship Research (7)
  7. Biostatistics Service (5)
  8. Epidemiology and Biostatistics (5)
  9. Radiation Oncology, Department of (5)
  10. Hematologic Malignancies, Division of (3)
Search Within
  1. "David Ilson"
  2. "Karyn Goodman"
Formats
  1. Meeting Abstract (10)
Groups
  1. Department of Medicine (10)
  2. Gastrointestinal Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
  4. Surgery (8)
  5. Center for Pancreatic Cancer Research (7)
  6. Survivorship Research (7)

More Groups

People
  1. David Ilson (10)
  2. Karyn Goodman (10)
  3. Nabil Rizk (8)
  4. Manjit Bains (7)
  5. Valerie Rusch (7)
  6. David Kelsen (5)

More People

Years
  1. 2017 (1)
  2. 2015 (2)
  3. 2014 (1)
  4. 2012 (2)
  5. 2010 (1)
  6. 2009 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer
    Meeting Abstract

    Goodman, K. A.; Niedzwiecki, D.; Hall, N.; Bekaii-Saab, T. S.; Ye, X.; Meyers, M. O.; Mitchell-Richards, K.; Boffa, D. J.; Frankel, W. L.; Venook, A. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Changing chemotherapy (C) with concurrent radiation (RT) followed by surgery after sub-optimal FDG-PET response to induction chemotherapy improves outcomes in locally advanced (LA) esophageal adenocarcinoma (EA)
    Meeting Abstract

    Kriplani, A.; Janjigian, Y. Y.; Kelsen, D. P.; Rusch, V. W.; Bains, M. S.; Rizk, N. P.; Chou, J. F.; Capanu, M.; Wu, A. J. C.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes after chemoradiation alone for adenocarcinoma of the esophagus and gastroesophageal junction
    Meeting Abstract

    Pham, A.; Goodman, K. A.; Ilson, D. H.; Janjigian, Y. Y.; Ku, G. Y.; Rizk, N. P.; Wu, A. J. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • FDG-PET scan after induction chemotherapy for esophageal squamous cell cancer (ESCC) to predict for outcomes after chemoradiation (chemoRT) and to guide salvage chemotherapy during RT
    Meeting Abstract

    Ku, G. Y.; Janjigian, Y. Y.; Kriplani, A.; Ong, L.; Rusch, V. W.; Bains, M. S.; Rizk, N. P.; Sarkaria, I. S.; Capanu, M.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Intensity-modulated radiotherapy for esophageal cancer: Analysis of toxicity and outcomes
    Meeting Abstract

    Kurshan, N.; Ilson, D.; Shah, M. A.; Kelsen, D. P.; Ho, A. Y.; Zhang, Z.; Mo, Q.; Goodman, K. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis
    Meeting Abstract

    Ilson, D.; Bains, M.; Rizk, N.; Rusch, V.; Flores, R.; Park, B.; Shah, M.; Kelsen, D.; Miron, B.; Goodman, K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The association of PET response with complete pathological response (CPR) and residual nodal disease (RND) after induction chemoradiotherapy (CRT) and resection of esophageal cancer: A review of 493 cases
    Meeting Abstract

    Barnett, S. A.; Rizk, N. P.; Adusumilli, P. S.; Park, B. J.; Bains, M. S.; Flores, R. M.; Goodman, K. A.; Ilson, D. H.; Akhurst, T. J.; Rusch, V. W.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Use of SUVmax to predict response to neoadjuvant chemoradiotherapy in patients with adenocarcinoma of the distal esophagus and GE junction
    Meeting Abstract

    Rizk, N. P.; Bains, M. S.; Park, B. J.; Flores, R. M.; Downey, R. J.; Goodman, K.; Ilson, D. H.; Rusch, V. W.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save